TechNet-21 - Forum

This forum provides a place for members to ask questions, share experiences, coordinate activities, and discuss recent developments in immunization.
  1. Moderator
  2. Service delivery
  3. Tuesday, 24 April 2012
Many thanks to Diana Chang Blanc for sharing this information with the forum! Dear colleagues, ... Please find below the web link to the “first batch” of the WHO Information Sheets on Observed Rates of Vaccine Reactions. We would highly welcome if you could share these sheets with colleagues and relevant target groups. At this link you will find the information sheets aiming to provide details on observed rates of vaccine reactions of selected vaccines. They can be used in the evaluation of Adverse Events Following Immunization (AEFI) reported during national immunization programs, but also in preparing communication materials about specific vaccines. Primarily, these sheets are designed for use by national public health officials and immunization programme managers but may appeal to others interested in such information. The information sheets have been developed and reviewed internally and externally in collaboration with the respective WHO Vaccine Focal Points and the Global Advisory Committee on Vaccine Safety (GACVS). We would like to particularly thank the Vaccine focal points from IVB, IVR (Ulrich Fruth) and FOS (Simone Magnino) for their great support in the development of the first available Information Sheets, and we thank the Global Advisory Committee that has helped in the further refinement of these information products. Attached is also flyer/poster to the information sheets that may be helpful for your further communication to colleagues and target groups. VaccRate-Infosheet-Poster.pdf We look forward to keep you posted on the next publication of the remaining sheets in the course of this year. Best regards Philipp Dr Philipp Lambach Global Vaccine Safety (GVS) Quality, Safety & Standards (QSS) Immunization, Vaccines and Biologicals (IVB) Tel. direct: +41 22 7911461 E-mail:

There are no replies made for this post yet.
Be one of the first to reply to this post!